Parkinson’’s disease: diagnostic relevance of elevated levels of soluble αα-synuclein oligomers in cerebrospinal fluid

ISSN： 1479-6708

Source： Future Neurology, Vol.6, Iss.2, 2011-03, pp. : 159-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DJ-1 and -synuclein in human cerebrospinal fluid as biomarkers of Parkinsons disease

By Hong Zhen

Brain, Vol. 133, Iss. 3, 2010-03 ,pp. : 713-726

Oxford University Press

Access to resources Recommend Favorite

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

By Maarouf Chera L Beach Thomas G Adler Charles H Shill Holly A Sabbagh Marwan N Wu Terence Walker Douglas G Kokjohn Tyler A Roher Alex E PD Consortium Arizona

Neurological Research, Vol. 34, Iss. 7, 2012-09 ,pp. : 669-676

Maney Publishing

Access to resources Recommend Favorite

Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

By Paleologou Katerina E.

Brain, Vol. 132, Iss. 4, 2009-04 ,pp. : 1093-1101

Oxford University Press

Access to resources Recommend Favorite

α-Synuclein pathology in the neostriatum in Parkinson’s disease

By Mori Fumiaki Tanji Kunikazu Zhang Haixin Kakita Akiyoshi Takahashi Hitoshi Wakabayashi Koichi

Acta Neuropathologica, Vol. 115, Iss. 4, 2008-04 ,pp. : 453-459

Springer Publishing Company

Access to resources Recommend Favorite

The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy

By Lee P. H. Lee G. Park H. J. Bang O. Y. Joo I. S. Huh K.

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1435-1439

Springer Publishing Company

Access to resources Recommend Favorite